Securing retatrutide can be a challenge for many. Currently, the drug is restricted and necessitates a prescription from a doctor . Receiving retatrutide typically involves participating in a clinical trial , though anticipated expanded distribution through traditional pharmaceutical channels is under review – though the schedule for this remains